AZD5363
ICR-CTSU/2012/10037
Phase 2 small_molecule active
Quick answer
AZD5363 for Adenocarcinoma of the Prostate is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Adenocarcinoma of the Prostate
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active